Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors

Journal of Neuro-Oncology

Volumn 109, Issue 2, 2012, Pages 425-432

  Ogura, Kengo ^a   Mizowaki, Takashi ^a   Ogura, Masakazu ^a   Sakanaka, Katsuyuki ^a   Arakawa, Yoshiki ^a   Miyamoto, Susumu ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Hypofractionated; Local control; Metastatic brain tumors; Stereotactic radiotherapy; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN METASTASIS; BRAIN RADIATION; BRAIN STEM INJURY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CONTRAST ENHANCEMENT; CONVULSION; FEMALE; FOLLOW UP; GAIT DISORDER; GRAND MAL SEIZURE; HUMAN; HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY; JAPAN; KARNOFSKY PERFORMANCE STATUS; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROBABILITY; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RISK FACTOR; SEIZURE; STEREOTACTIC PROCEDURE; TREATMENT PLANNING; TREATMENT REFUSAL; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84866008141     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0912-6     Document Type: Article

References (31)

1. Soffietti R, Ruda R, Trevisan E (2008) Brain metastases: current management and new developments. Curr Opin Oncol 20:676-684. doi:10.1097/CCO.0b013e32831186fe
2. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485-1489 (Pubitemid 28507400)
3. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494-500. doi:10.1056/NEJM199002223220802 (Pubitemid 20067825)
4. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665-1672. doi:10.1016/S0140-6736 (04) 16250-8 (Pubitemid 38670323)
5. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483-2491. doi:10.1001/jama.295. 21.2483 (Pubitemid 43854963)
6. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134-141. doi:10.1200/JCO. 2010.30.1655
7. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291-298 (Pubitemid 30236367)
8. Williams BJ, Suki D, Fox BD, Pelloski CE, Maldaun MV, Sawaya RE, Lang FF, Rao G (2009) Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 111:439-448. doi:10.3171/2008.11. JNS08984
9. Brenner DJ, Martel MK, Hall EJ (1991) Fractionated regimens for stereotactic radiotherapy of recurrent tumors in the brain. Int J Radiat Oncol Biol Phys 21:819-824
10. Hall EJ, Brenner DJ (1993) The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys 25:381-385 (Pubitemid 23048798)
11. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751 (Pubitemid 27181303)
12. Takakura T, Mizowaki T, Nakata M, Yano S, Fujimoto T, Miyabe Y, Nakamura M, Hiraoka M (2010) The geometric accuracy of frameless stereotactic radiosurgery using a 6D robotic couch system. Phys Med Biol 55:1-10. doi:10.1088/0031-9155/55/1/001
13. Kelly PJ, Lin YB, Yu AY, Ropper AE, Nguyen PL, Marcus KJ, Hacker FL, Weiss SE (2011) Linear accelerator-based stereotactic radiosurgery for brainstem metastases: the Dana-Farber/Brigham and Women's Cancer Center experience. J Neurooncol 104:553-557. doi:10.1007/s11060-010-0514-0
14. Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, Robinson PD, Ammirati M, Cobbs CS, Gaspar LE, Loeffler JS, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Ryken TC, Kalkanis SN (2010) The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidencebased clinical practice guideline. J Neurooncol 96:45-68. doi:10.1007/s11060-009-0073-4
15. Matsuo T, Shibata S, Yasunaga A, Iwanaga M, Mori K, Shimizu T, Hayashi N, Ochi M, Hayashi K (1999) Dose optimization and indication of Linac radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 45:931-939 (Pubitemid 29525457)
16. Vogelbaum MA, Angelov L, Lee SY, Li L, Barnett GH, Suh JH (2006) Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 104:907-912. doi:10.3171/jns.2006.104.6.907 (Pubitemid 43824740)
17. Schomas DA, Roeske JC, MacDonald RL, Sweeney PJ, Mehta N, Mundt AJ (2005) Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol 28:180-187
18. Molenaar R, Wiggenraad R, Verbeek-de Kanter A, Walchenbach R, Vecht C (2009) Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg 23:170-178. doi:10.1080/02688690902755613
19. Chang EL, Hassenbusch SJ III, Shiu AS, Lang FF, Allen PK, Sawaya R, Maor MH (2003) The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery 53:272-280, discussion 280-281
20. Shehata MK, Young B, Reid B, Patchell RA, St Clair W, Sims J, Sanders M, Meigooni A, Mohiuddin M, Regine WF (2004) Stereotatic radiosurgery of 468 brain metastases \ or =2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 59:87-93. doi:10.1016/j.ijrobp. 2003. 10.009 (Pubitemid 38501511)
21. Manning MA, Cardinale RM, Benedict SH, Kavanagh BD, Zwicker RD, Amir C, Broaddus WC (2000) Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys 47:603-608 (Pubitemid 30317477)
22. Ikushima H, Tokuuye K, Sumi M, Kagami Y, Murayama S, Ikeda H, Tanaka M, Oyama H, Shibui S, Nomura K (2000) Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 48:1389-1393
23. Aoyama H, Shirato H, Onimaru R, Kagei K, Ikeda J, Ishii N, Sawamura Y, Miyasaka K (2003) Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 56:793-800 (Pubitemid 36677374)
24. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G (2006) Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 81:18-24. doi:10.1016/j. radonc.2006.08.024 (Pubitemid 44540233)
25. Narayana A, Chang J, Yenice K, Chan K, Lymberis S, Brennan C, Gutin PH (2007) Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases. Stereotact Funct Neurosurg 85:82-87. doi:10.1159/000097923 (Pubitemid 46398365)
26. Fahrig A, Ganslandt O, Lambrecht U, Grabenbauer G, Kleinert G, Sauer R, Hamm K (2007) Hypofractionated stereotactic radiotherapy for brain metastases-results from three different dose concepts. Strahlenther Onkol 183:625-630. doi:10.1007/s00066-007-1714-1 (Pubitemid 350124271)
27. Kwon AK, Dibiase SJ, Wang B, Hughes SL, Milcarek B, Zhu Y (2009) Hypofractionated stereotactic radiotherapy for the treatment of brain metastases. Cancer 115:890-898. doi:10.1002/cncr.24082
28. Kim YJ, Cho KH, Kim JY, Lim YK, Min HS, Lee SH, Kim HJ, Gwak HS, Yoo H (2011) Single-dose versus fractionated stereotactic radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 81:483-489. doi:10.1016/j.ijrobp. 2010.05.033
29. Wiggenraad R, Verbeek-de Kanter A, Kal HB, Taphoorn M, Vissers T, Struikmans H (2011) Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol 98:292-297. doi:10.1016/j.radonc.2011.01.011
30. Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY (2009) CNS complications of radiotherapy and chemotherapy. Lancet 374:1639-1651. doi:10.1016/S0140-6736 (09) 61299-X
31. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar AK, Kondziolka D, Lunsford LD (2003) Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 57:452-464 (Pubitemid 37040942)